EMA advisor discusses real-world data and single-arm trials in oncology drug approvals

Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on

GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer

GSK announced submission of MAA to EMEA for pazopanib, oral therapy for metastatic renal cell carcinoma (RCC).

Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer

Conditions : Pancreatic Ductal Adenocarcinoma (PDAC) Sponsors : Beijing Daxiang Biotech Co., Ltd; Ruijin Hospital; Beijing Friendship Hospit

Personalized Treatment Strategies for HER2-Positive Gastroesophageal Adenocarcinoma

Stay current with evolving strategies for HER2-positive gastroesophageal adenocarcinoman (GEA). Improve your practice with continuing educat

<![CDATA[Pharmacist-Led Workflows Support Safe Outpatient BiTE Therapy in Multiple Myeloma]]>

Natera's Signatera Wins EU Certification for Cancer Recurrence Monitoring

Certification allows Natera to keep offering the cancer-recurrence test across the EU as the bloc phases out its previous device framework.